Neuroscience contract research services
As an innovative and dynamic contract research organization (CRO) InnoSer supports the preclinical pipeline from its facilities in Belgium and the Netherlands. Founded in 2012, our in-depth expertise allows us to provide customized and streamlined early drug development options with well-characterized and near-patient research models. Recently acquiring Sylics our neurology platform has been further expanded, increasing the scope of neurology disease models we now offer our partners. These models include; Fmr1 (FMRP, FRX) Stxbp1 (autism, epilepsy) Eif2B (leukodystrophy) APP/PS1 (Alzheimer) 22q11 PS19 (P301S, tauopathy) MPTP M83 (alpha-synuclein) Seeding (tau, aSyn) ALS (TDP-43, SOD1) FTD (TDP43) APOE, and are combined with a comprehensive portfolio of sensitive and translational behavioral tests.
Our services are designed with personalized tailoring in mind, supported by innovative technical capabilities and are executed in close collaboration with our partners.
Brands: AHCODA
CognitionWall